More Than Just Dander
First, a sort of meta-comment in the form of a shout-out to HCRenewal's intrepid editor, Dr. Roy Poses, for his just-published analysis of what we might call " blogging: rise and fall. " He sees decline reflected in publications long devoted to health and health policy, yet now flaking off.Methinks, however, despite the usefulness of his overview of recent decades, Dr. P need not fret excessively. Water spilling out of the barrel's lip will slow down once folks come along and punch a whole bunch of little mid-section tweet-holes in it. Information still flows. (Sort of.) In any case, surely there's overlap between blogs'and tweets'readerships. Surely well-researched and -reasoned long form still has its place. Unfortunately, hard to know for sure: it's hard to measure. Nobody's polling these folks and to my knowledge information scientists haven't published much--a quick search inside Google Scholar bears this out--that's of a quantitative nature.So we're left with admittedly rather unsatisfactory anecdotal reports on people who need blogs like ours and find their way to it. Congressional staffers you know who you are. Rightly or wrongly, I'm hopeful. Maybe we shade this a little by the suspicion that many younger social media users share with me a short attention span. Hence they come to rely more and more on quick hits. In any case, let's hope this is evolution and diversification, not just entropy and a race to the bottom.Now to my theme of the day. Y...
Area I work has very high marijuana use in the community and a portion of these patients I would classify as heavy users ( smoke or vape>3 grams per day), vast majority of users are 0.5-1 g daily. Among the very heavy users, I had noted a few oddities: 40ish male coming in for ureteroscopy developed severe bronchospasm on pushing propofol, no airway manipulation or moving of patient by surgeon. About 90 kg, received 400 mg. Became rigid and notable myoclonus. Bronchospasm broke with ppv... Heavy marijuana users
A 48-year-old male presented with worsening gait instability, blurry vision, headache, and intermittent emesis over a 4-month period. Magnetic resonance imaging of the brain demonstrated a right ventricular mass at the foramen of Monro with associated obstructive hydrocephalus (Fig 1). The lesion was well circumscribed and nonenhancing and measured 1.9 cm × 1.9 cm × 2.1 cm with minimal surrounding edema. A computed tomography scan of the chest/abdomen/pelvis showed no evidence of extracranial disease.
Condition: Healthy Interventions: Drug: Lysergic Acid Diethylamide; Drug: Ketanserin Placebo; Drug: Ketanserin Sponsor: University Hospital, Basel, Switzerland Not yet recruiting
Conditions: Rib Fractures; Trauma; Anesthesia; Anesthesia, Local Intervention: Drug: Continuous erector spinae plane nerve block Sponsor: University of California, San Diego Not yet recruiting
Condition: Anesthesia Complication Intervention: Sponsor: Massachusetts Eye and Ear Infirmary Completed
Condition: Thoracic Surgery Interventions: Drug: Liposomal Bupivacaine (EXPAREL®)/Bupivacaine; Drug: Ropivacaine 0.5% BOLUS followed by Ropivacaine 0.2% Sponsor: The Guthrie Clinic Not yet recruiting
Condition: Cicatrix, Hypertrophic Intervention: Device: Extracorporal Shock Wave Therapy Sponsor: Hospital Universitari Vall d'Hebron Research Institute Completed
Conditions: Type 1 Diabetes; Continuous Glucose Monitoring; Children; Glucose Variability Intervention: Sponsors: University of Ljubljana, Faculty of Medicine; International Society for Pediatric and Adolescent Diabetes; Kinderkrankenhaus auf der Bult, Hannover, Germany; Department of Pediatrcs, Endocrinology and Diabetes Medical University of Silesia in Katowice, Poland; Pediatric Dia betes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hosp...
Condition: Malaria Intervention: Diagnostic Test: Novel in vitro diagnostics and medical applications Sponsor: Foundation for Innovative New Diagnostics, Switzerland Not yet recruiting
Condition: Malaria Intervention: Diagnostic Test: Novel malaria diagnostics&tools Sponsor: Foundation for Innovative New Diagnostics, Switzerland Not yet recruiting
More News: Addiction | Agency for Healthcare Research and Quality (AHRQ) | American Health | Anesthesia | Anesthesiology | Babies | Blindness | Blogging | Burns | Economic Slowdown | Education | Environmental Health | Eyes | Government | Headache | Health Management | Hospitals | Hydrocodone | Hypermetropia (long sighted) | Insurance | Internal Medicine | Internet | Learning | Legislation | Lortab | Medical Ethics | Migraine | Opthalmology | Oxycodone | OxyContin | Percocet | Pharmaceuticals | Poisoning | Politics | Science | Smokers | Study | Switzerland Health | Trump | Universities & Medical Training | USA Health | Vicodin